Inflammasome as an Effective Platform for Fibrosis Therapy

References

• Evavold CL, Kagan JC. How inflammasomes inform adaptive immunity. J Mol Biol. 2018;430(2):217–237. doi:10.1016/j.jmb.2017.09.019
   PubMed Web of Science ®Google Scholar
• Fernandes FP, Leal VNC, Souza de Lima D, et al. Inflammasome genetics and complex diseases: a comprehensive review. Eur J Hum Genet. 2020;28(10):1307–1321. doi:10.1038/s41431-020-0631-y
   PubMed Web of Science ®Google Scholar
• Cordero MD, Alcocer-Gomez E. Editorial: inflammasome complex in health and disease: new pharmacological perspectives. Curr Drug Targets. 2017;18(9):996. doi:10.2174/1389450118666161123153230
   PubMed Web of Science ®Google Scholar
• Artlett CM. Inflammasomes in wound healing and fibrosis. J Pathol. 2013;229(2):157–167. doi:10.1002/path.4116
   PubMed Web of Science ®Google Scholar
• Rathinam VA, Fitzgerald KA. Inflammasome complexes: emerging mechanisms and effector functions. Cell. 2016;165(4):792–800. doi:10.1016/j.cell.2016.03.046
   PubMed Web of Science ®Google Scholar
• Ouyang X, Ghani A, Mehal WZ. Inflammasome biology in fibrogenesis. Biochim Biophys Acta. 2013;1832(7):979–988. doi:10.1016/j.bbadis.2013.03.020
   PubMed Web of Science ®Google Scholar
• Gu YJ, Sun WY, Zhang S, Wu JJ, Wei W. The emerging roles of β-arrestins in fibrotic diseases. Acta Pharmacol Sin. 2015;36(11):1277–1287. doi:10.1038/aps.2015.74
   PubMed Web of Science ®Google Scholar
• Xiong W, Meng XF, Zhang C. Inflammasome activation in podocytes: a new mechanism of glomerular diseases. Inflamm Res. 2020;69(8):731–743. doi:10.1007/s00011-020-01354-w
   PubMed Web of Science ®Google Scholar
• Gong T, Jiang W, Zhou R. Control of inflammasome activation by phosphorylation. Trends Biochem Sci. 2018;43(9):685–699. doi:10.1016/j.tibs.2018.06.008
   PubMed Web of Science ®Google Scholar
• Place DE, Kanneganti TD. Recent advances in inflammasome biology. Curr Opin Immunol. 2018;50:32–38. doi:10.1016/j.coi.2017.10.011
   PubMed Web of Science ®Google Scholar
• Lamkanfi M, Dixit VM. Mechanisms and functions of inflammasomes. Cell. 2014;157(5):1013–1022. doi:10.1016/j.cell.2014.04.007
   PubMed Web of Science ®Google Scholar
• Evavold CL, Kagan JC. Inflammasomes: threat-assessment organelles of the innate immune system. Immunity. 2019;51(4):609–624. doi:10.1016/j.immuni.2019.08.005
   PubMed Web of Science ®Google Scholar
• Lupfer C, Kanneganti TD. Unsolved mysteries in NLR biology. Front Immunol. 2013;4:285. doi:10.3389/fimmu.2013.00285
   PubMed Web of Science ®Google Scholar
• Malik A, Kanneganti TD. Inflammasome activation and assembly at a glance. J Cell Sci. 2017;130(23):3955–3963. doi:10.1242/jcs.207365
   PubMed Web of Science ®Google Scholar
• Yang Q, Liu R, Yu Q, Bi Y, Liu G. Metabolic regulation of inflammasomes in inflammation. Immunology. 2019;157(2):95–109. doi:10.1111/imm.13056
   PubMed Web of Science ®Google Scholar
• Wang B, Tian Y, Yin Q. AIM2 inflammasome assembly and signaling. Adv Exp Med Biol. 2019;1172:143–155.
   PubMed Web of Science ®Google Scholar
• Cridland JA, Curley EZ, Wykes MN, et al. The mammalian PYHIN gene family: phylogeny, evolution and expression. BMC Evol Biol. 2012;12:140. doi:10.1186/1471-2148-12-140
   PubMed Web of Science ®Google Scholar
• Van Opdenbosch N, Lamkanfi M. Caspases in cell death, inflammation, and disease. Immunity. 2019;50(6):1352–1364. doi:10.1016/j.immuni.2019.05.020
   PubMed Web of Science ®Google Scholar
• Shi C, Yang H, Zhang Z. Involvement of nucleotide-binding oligomerization domain-like receptor family pyrin domain containing 3 inflammasome in the pathogenesis of liver diseases. Front Cell Dev Biol. 2020;8:139. doi:10.3389/fcell.2020.00139
   PubMed Web of Science ®Google Scholar
• de Alba E. Structure, interactions and self-assembly of ASC-dependent inflammasomes. Arch Biochem Biophys. 2019;670:15–31. doi:10.1016/j.abb.2019.05.023
   PubMed Web of Science ®Google Scholar
• Jin T, Curry J, Smith P, Jiang J, Xiao TS. Structure of the NLRP1 caspase recruitment domain suggests potential mechanisms for its association with procaspase-1. Proteins. 2013;81(7):1266–1270. doi:10.1002/prot.24287
   PubMed Web of Science ®Google Scholar
• Guey B, Bodnar M, Manié SN, Tardivel A, Petrilli V. Caspase-1 autoproteolysis is differentially required for NLRP1b and NLRP3 inflammasome function. Proc Natl Acad Sci U S A. 2014;111(48):17254–17259. doi:10.1073/pnas.1415756111
   PubMed Web of Science ®Google Scholar
• Van Opdenbosch N, Gurung P, Vande Walle L, Fossoul A, Kanneganti TD, Lamkanfi M. Activation of the NLRP1b inflammasome independently of ASC-mediated caspase-1 autoproteolysis and speck formation. Nat Commun. 2014;5:3209. doi:10.1038/ncomms4209
   PubMed Web of Science ®Google Scholar
• Guo H, Callaway JB, Ting JP. Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat Med. 2015;21(7):677–687. doi:10.1038/nm.3893
   PubMed Web of Science ®Google Scholar
• Davis BK, Wen H, Ting JP. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol. 2011;29:707–735. doi:10.1146/annurev-immunol-031210-101405
   PubMed Web of Science ®Google Scholar
• Alegre F, Pelegrin P, Feldstein AE. Inflammasomes in Liver Fibrosis. Semin Liver Dis. 2017;37(2):119–127. doi:10.1055/s-0037-1601350
   PubMed Web of Science ®Google Scholar
• Richardson MB, Williams SJ. MCL and mincle: c-type lectin receptors that sense damaged self and pathogen-associated molecular patterns. Front Immunol. 2014;5:288. doi:10.3389/fimmu.2014.00288
   PubMed Web of Science ®Google Scholar
• Magdaleno F, Blajszczak CC, Nieto N. Key events participating in the pathogenesis of alcoholic liver disease. Biomolecules. 2017;7(4):9. doi:10.3390/biom7010009
   PubMedGoogle Scholar
• Mangan MSJ, Olhava EJ, Roush WR, Seidel HM, Glick GD, Latz E. Targeting the NLRP3 inflammasome in inflammatory diseases. Nat Rev Drug Discov. 2018;17(9):688. doi:10.1038/nrd.2018.149
   PubMed Web of Science ®Google Scholar
• Muñoz-Planillo R, Kuffa P, Martínez-Colón G, Smith BL, Rajendiran TM, Núñez G. K+ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity. 2013;38(6):1142–1153. doi:10.1016/j.immuni.2013.05.016
   PubMed Web of Science ®Google Scholar
• Pétrilli V, Papin S, Dostert C, Mayor A, Martinon F, Tschopp J. Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ. 2007;14(9):1583–1589. doi:10.1038/sj.cdd.4402195
   PubMed Web of Science ®Google Scholar
• Wolf AJ, Reyes CN, Liang W, et al. Hexokinase is an innate immune receptor for the detection of bacterial peptidoglycan. Cell. 2016;166(3):624–636. doi:10.1016/j.cell.2016.05.076
   PubMed Web of Science ®Google Scholar
• Bauernfeind FG, Horvath G, Stutz A, et al. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol. 2009;183(2):787–791. doi:10.4049/jimmunol.0901363
   PubMed Web of Science ®Google Scholar
• Kelley N, Jeltema D, Duan Y, He Y. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci. 2019;20(13):3328. doi:10.3390/ijms20133328
   PubMed Web of Science ®Google Scholar
• Elliott EI, Sutterwala FS. Initiation and perpetuation of NLRP3 inflammasome activation and assembly. Immunol Rev. 2015;265(1):35–52. doi:10.1111/imr.12286
   PubMed Web of Science ®Google Scholar
• Ranson N, Kunde D, Eri R. Regulation and sensing of inflammasomes and their impact on intestinal health. Int J Mol Sci. 2017;18(11):2379. doi:10.3390/ijms18112379
   PubMed Web of Science ®Google Scholar
• Broz P, von Moltke J, Jones JW, Vance RE, Monack DM. Differential requirement for Caspase-1 autoproteolysis in pathogen-induced cell death and cytokine processing. Cell Host Microbe. 2010;8(6):471–483. doi:10.1016/j.chom.2010.11.007
   PubMed Web of Science ®Google Scholar
• Roth S, Ruland J. Caspase recruitment domain-containing protein 9 signaling in innate immunity and inflammation. Trends Immunol. 2013;34(6):243–250. doi:10.1016/j.it.2013.02.006
   PubMed Web of Science ®Google Scholar
• Shi J, Zhao Y, Wang K, et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 2015;526(7575):660–665. doi:10.1038/nature15514
   PubMed Web of Science ®Google Scholar
• Shi J, Gao W, Shao F. Pyroptosis: gasdermin-mediated programmed necrotic cell death. Trends Biochem Sci. 2017;42(4):245–254. doi:10.1016/j.tibs.2016.10.004
   PubMed Web of Science ®Google Scholar
• Rühl S, Broz P. Caspase-11 activates a canonical NLRP3 inflammasome by promoting K(+) efflux. Eur J Immunol. 2015;45(10):2927–2936. doi:10.1002/eji.201545772
   PubMed Web of Science ®Google Scholar
• Roberts TL, Idris A, Dunn JA, et al. HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science. 2009;323(5917):1057–1060. doi:10.1126/science.1169841
   PubMed Web of Science ®Google Scholar
• Jin T, Perry A, Jiang J, et al. Structures of the HIN domain: DNA complexes reveal ligand binding and activation mechanisms of the AIM2 inflammasome and IFI16 receptor. Immunity. 2012;36(4):561–571. doi:10.1016/j.immuni.2012.02.014
   PubMed Web of Science ®Google Scholar
• Hornung V, Ablasser A, Charrel-Dennis M, et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature. 2009;458(7237):514–518. doi:10.1038/nature07725
   PubMed Web of Science ®Google Scholar
• Lugrin J, Martinon F. The AIM2 inflammasome: sensor of pathogens and cellular perturbations. Immunol Rev. 2018;281(1):99–114. doi:10.1111/imr.12618
   PubMed Web of Science ®Google Scholar
• Rathinam VA, Jiang Z, Waggoner SN, et al. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat Immunol. 2010;11(5):395–402. doi:10.1038/ni.1864
   PubMed Web of Science ®Google Scholar
• Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol. 2009;1(6):a001651. doi:10.1101/cshperspect.a001651
   PubMed Web of Science ®Google Scholar
• White S, Lin L, Hu K. NF-κB and tPA signaling in kidney and other diseases. Cells. 2020;9(6):1348. doi:10.3390/cells9061348
   PubMed Web of Science ®Google Scholar
• Luedde T, Schwabe RF. NF-κB in the liver–linking injury, fibrosis and hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2011;8(2):108–118. doi:10.1038/nrgastro.2010.213
   PubMed Web of Science ®Google Scholar
• Jiang Q, Liu P, Wu X, et al. Berberine attenuates lipopolysaccharide-induced extracelluar matrix accumulation and inflammation in rat mesangial cells: involvement of NF-κB signaling pathway. Mol Cell Endocrinol. 2011;331(1):34–40. doi:10.1016/j.mce.2010.07.023
   PubMed Web of Science ®Google Scholar
• Shao BZ, Wang SL, Pan P, et al. Targeting NLRP3 inflammasome in inflammatory bowel disease: putting out the fire of inflammation. Inflammation. 2019;42(4):1147–1159. doi:10.1007/s10753-019-01008-y
   PubMed Web of Science ®Google Scholar
• Pinar AA, Scott TE, Huuskes BM, Tapia Cáceres FE, Kemp-Harper BK, Samuel CS. Targeting the NLRP3 inflammasome to treat cardiovascular fibrosis. Pharmacol Ther. 2020;209:107511.
   PubMed Web of Science ®Google Scholar
• Otto G. IL-1β switches on kidney fibrosis. Nat Rev Nephrol. 2018;14(8):475. doi:10.1038/s41581-018-0026-2
   PubMed Web of Science ®Google Scholar
• Chen G, Sun L, Kato T, et al. IL-1β dominates the promucin secretory cytokine profile in cystic fibrosis. J Clin Invest. 2019;129(10):4433–4450. doi:10.1172/JCI125669
   PubMed Web of Science ®Google Scholar
• Liang H, Xu F, Zhang T, et al. Inhibition of IL-18 reduces renal fibrosis after ischemia-reperfusion. Biomed Pharmacother. 2018;106:879–889. doi:10.1016/j.biopha.2018.07.031
   PubMed Web of Science ®Google Scholar
• Xiao H, Li H, Wang JJ, et al. IL-18 cleavage triggers cardiac inflammation and fibrosis upon β-adrenergic insult. Eur Heart J. 2018;39(1):60–69. doi:10.1093/eurheartj/ehx261
   PubMed Web of Science ®Google Scholar
• Goldbach-Mansky R, Kastner DL. Autoinflammation: the prominent role of IL–1 in monogenic autoinflammatory diseases and implications for common illnesses. J Allergy Clin Immunol. 2009;124(6):1141–1149; quiz 1150–1141. doi:10.1016/j.jaci.2009.11.016
   PubMed Web of Science ®Google Scholar
• Ding N, Wei B, Fu X, Wang C, Wu Y. Natural products that target the NLRP3 inflammasome to treat fibrosis. Front Pharmacol. 2020;11:591393. doi:10.3389/fphar.2020.591393
   PubMed Web of Science ®Google Scholar
• Hannum CH, Wilcox CJ, Arend WP, et al. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature. 1990;343(6256):336–340. doi:10.1038/343336a0
   PubMed Web of Science ®Google Scholar
• Jiang F, Liu GS, Dusting GJ, Chan EC. NADPH oxidase-dependent redox signaling in TGF-β-mediated fibrotic responses. Redox Biol. 2014;2:267–272. doi:10.1016/j.redox.2014.01.012
   PubMed Web of Science ®Google Scholar
• Sampson N, Berger P, Zenzmaier C. Redox signaling as a therapeutic target to inhibit myofibroblast activation in degenerative fibrotic disease. Biomed Res Int. 2014;2014:131737. doi:10.1155/2014/131737
   PubMed Web of Science ®Google Scholar
• Gorin Y, Block K, Hernandez J, et al. Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney. J Biol Chem. 2005;280(47):39616–39626. doi:10.1074/jbc.M502412200
   PubMed Web of Science ®Google Scholar
• Hecker L, Vittal R, Jones T, et al. NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat Med. 2009;15(9):1077–1081. doi:10.1038/nm.2005
   PubMed Web of Science ®Google Scholar
• Jiang JX, Chen X, Serizawa N, et al. Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo. Free Radic Biol Med. 2012;53(2):289–296. doi:10.1016/j.freeradbiomed.2012.05.007
   PubMed Web of Science ®Google Scholar
• Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol. 2010;11(2):136–140. doi:10.1038/ni.1831
   PubMed Web of Science ®Google Scholar
• Oslowski CM, Hara T, O’Sullivan-Murphy B, et al. Thioredoxin-interacting protein mediates ER stress-induced β cell death through initiation of the inflammasome. Cell Metab. 2012;16(2):265–273. doi:10.1016/j.cmet.2012.07.005
   PubMed Web of Science ®Google Scholar
• Kim SM, Kim YG, Kim DJ, et al. Inflammasome-independent role of NLRP3 mediates mitochondrial regulation in renal injury. Front Immunol. 2018;9:2563. doi:10.3389/fimmu.2018.02563
   PubMed Web of Science ®Google Scholar
• Gong W, Mao S, Yu J, et al. NLRP3 deletion protects against renal fibrosis and attenuates mitochondrial abnormality in mouse with 5/6 nephrectomy. Am J Physiol Renal Physiol. 2016;310(10):F1081–F1088. doi:10.1152/ajprenal.00534.2015
   PubMed Web of Science ®Google Scholar
• Guo H, Bi X, Zhou P, Zhu S, Ding W. NLRP3 deficiency attenuates renal fibrosis and ameliorates mitochondrial dysfunction in a mouse unilateral ureteral obstruction model of chronic kidney disease. Mediators Inflamm. 2017;2017:8316560. doi:10.1155/2017/8316560
   PubMed Web of Science ®Google Scholar
• Ide T, Tsutsui H, Hayashidani S, et al. Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction. Circ Res. 2001;88(5):529–535. doi:10.1161/01.RES.88.5.529
   PubMed Web of Science ®Google Scholar
• Alyaseer AAA, de Lima MHS, Braga TT. The role of NLRP3 inflammasome activation in the epithelial to mesenchymal transition process during the fibrosis. Front Immunol. 2020;11:883. doi:10.3389/fimmu.2020.00883
   PubMed Web of Science ®Google Scholar
• Hata A, Lo RS, Wotton D, Lagna G, Massagué J. Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4. Nature. 1997;388(6637):82–87. doi:10.1038/40424
   PubMed Web of Science ®Google Scholar
• Sanderson N, Factor V, Nagy P, et al. Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci U S A. 1995;92(7):2572–2576. doi:10.1073/pnas.92.7.2572
   PubMed Web of Science ®Google Scholar
• Kopp JB, Factor VM, Mozes M, et al. Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease. Lab Invest. 1996;74(6):991–1003.
   PubMed Web of Science ®Google Scholar
• Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 2003;425(6958):577–584. doi:10.1038/nature02006
   PubMed Web of Science ®Google Scholar
• Zhang LL, Huang S, Ma XX, et al. Angiotensin(1-7) attenuated Angiotensin II-induced hepatocyte EMT by inhibiting NOX-derived H2O2-activated NLRP3 inflammasome/IL-1β/Smad circuit. Free Radic Biol Med. 2016;97:531–543. doi:10.1016/j.freeradbiomed.2016.07.014
   PubMed Web of Science ®Google Scholar
• Doerner AM, Zuraw BL. TGF-beta1 induced epithelial to mesenchymal transition (EMT) in human bronchial epithelial cells is enhanced by IL-1beta but not abrogated by corticosteroids. Respir Res. 2009;10(1):100. doi:10.1186/1465-9921-10-100
   PubMedGoogle Scholar
• Tian R, Zhu Y, Yao J, et al. NLRP3 participates in the regulation of EMT in bleomycin-induced pulmonary fibrosis. Exp Cell Res. 2017;357(2):328–334. doi:10.1016/j.yexcr.2017.05.028
   PubMed Web of Science ®Google Scholar
• Song S, Qiu D, Luo F, et al. Knockdown of NLRP3 alleviates high glucose or TGFB1-induced EMT in human renal tubular cells. J Mol Endocrinol. 2018;61(3):101–113. doi:10.1530/JME-18-0069
   PubMed Web of Science ®Google Scholar
• Romero CA, Remor A, Latini A, De Paul AL, Torres AI, Mukdsi JH. Uric acid activates NRLP3 inflammasome in an in-vivo model of epithelial to mesenchymal transition in the kidney. J Mol Histol. 2017;48(3):209–218. doi:10.1007/s10735-017-9720-9
   PubMed Web of Science ®Google Scholar
• Wu M, Han W, Song S, et al. NLRP3 deficiency ameliorates renal inflammation and fibrosis in diabetic mice. Mol Cell Endocrinol. 2018;478:115–125. doi:10.1016/j.mce.2018.08.002
   PubMed Web of Science ®Google Scholar
• Wang W, Wang X, Chun J, et al. Inflammasome-independent NLRP3 augments TGF-β signaling in kidney epithelium. J Immunol. 2013;190(3):1239–1249. doi:10.4049/jimmunol.1201959
   PubMed Web of Science ®Google Scholar
• Zhang YE. Non-Smad pathways in TGF-beta signaling. Cell Res. 2009;19(1):128–139. doi:10.1038/cr.2008.328
   PubMed Web of Science ®Google Scholar
• Higashi T, Friedman SL, Hoshida Y. Hepatic stellate cells as key target in liver fibrosis. Adv Drug Deliv Rev. 2017;121:27–42.
   PubMed Web of Science ®Google Scholar
• Wynn TA, Ramalingam TR. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med. 2012;18(7):1028–1040. doi:10.1038/nm.2807
   PubMed Web of Science ®Google Scholar
• Luan J, Ju D. Inflammasome: a double-edged sword in liver diseases. Front Immunol. 2018;9:2201. doi:10.3389/fimmu.2018.02201
   PubMed Web of Science ®Google Scholar
• Artlett CM. The IL-1 family of cytokines. Do they have a role in scleroderma fibrosis? Immunol Lett. 2018;195:30–37. doi:10.1016/j.imlet.2017.11.012
   PubMed Web of Science ®Google Scholar
• Boaru SG, Borkham-Kamphorst E, Tihaa L, Haas U, Weiskirchen R. Expression analysis of inflammasomes in experimental models of inflammatory and fibrotic liver disease. J Inflamm (Lond). 2012;9(1):49. doi:10.1186/1476-9255-9-49
   PubMedGoogle Scholar
• Wu X, Zhang F, Xiong X, et al. Tetramethylpyrazine reduces inflammation in liver fibrosis and inhibits inflammatory cytokine expression in hepatic stellate cells by modulating NLRP3 inflammasome pathway. IUBMB Life. 2015;67(4):312–321. doi:10.1002/iub.1348
   PubMed Web of Science ®Google Scholar
• Inzaugarat ME, Johnson CD, Holtmann TM, et al. NLR family pyrin domain-containing 3 inflammasome activation in hepatic stellate cells induces liver fibrosis in mice. Hepatology. 2019;69(2):845–859. doi:10.1002/hep.30252
   PubMed Web of Science ®Google Scholar
• Yaping Z, Ying W, Luqin D, Ning T, Xuemei A, Xixian Y. Mechanism of interleukin-1β-induced proliferation in rat hepatic stellate cells from different levels of signal transduction. APMIS. 2014;122(5):392–398. doi:10.1111/apm.12155
   PubMed Web of Science ®Google Scholar
• Reiter FP, Wimmer R, Wottke L, et al. Role of interleukin-1 and its antagonism of hepatic stellate cell proliferation and liver fibrosis in the Abcb4(-/-) mouse model. World J Hepatol. 2016;8(8):401–410. doi:10.4254/wjh.v8.i8.401
   PubMedGoogle Scholar
• Yan C, Zhou L, Han YP. Contribution of hepatic stellate cells and matrix metalloproteinase 9 in acute liver failure. Liver Int. 2008;28(7):959–971. doi:10.1111/j.1478-3231.2008.01775.x
   PubMed Web of Science ®Google Scholar
• Miura K, Kodama Y, Inokuchi S, et al. Toll-like receptor 9 promotes steatohepatitis by induction of interleukin–1beta in mice. Gastroenterology. 2010;139(1):323–334.e327. doi:10.1053/j.gastro.2010.03.052
   PubMed Web of Science ®Google Scholar
• Kamari Y, Shaish A, Vax E, et al. Lack of interleukin-1α or interleukin-1β inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice. J Hepatol. 2011;55(5):1086–1094. doi:10.1016/j.jhep.2011.01.048
   PubMed Web of Science ®Google Scholar
• Dixon LJ, Flask CA, Papouchado BG, Feldstein AE, Nagy LE. Caspase-1 as a central regulator of high fat diet-induced non-alcoholic steatohepatitis. PLoS One. 2013;8(2):e56100. doi:10.1371/journal.pone.0056100
   PubMed Web of Science ®Google Scholar
• Dixon LJ, Berk M, Thapaliya S, Papouchado BG, Feldstein AE. Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis. Lab Invest. 2012;92(5):713–723. doi:10.1038/labinvest.2012.45
   PubMed Web of Science ®Google Scholar
• Sansoè G, Aragno M, Wong F. Pathways of hepatic and renal damage through non-classical activation of the renin-angiotensin system in chronic liver disease. Liver Int. 2020;40(1):18–31. doi:10.1111/liv.14272
   PubMed Web of Science ®Google Scholar
• Cai SM, Yang RQ, Li Y, et al. Angiotensin-(1-7) improves liver fibrosis by regulating the NLRP3 inflammasome via redox balance modulation. Antioxid Redox Signal. 2016;24(14):795–812. doi:10.1089/ars.2015.6498
   PubMed Web of Science ®Google Scholar
• Dong Z, Zhuang Q, Ning M, Wu S, Lu L, Wan X. Palmitic acid stimulates NLRP3 inflammasome activation through TLR4-NF-κB signal pathway in hepatic stellate cells. Ann Transl Med. 2020;8(5):168. doi:10.21037/atm.2020.02.21
   PubMed Web of Science ®Google Scholar
• Han CY, Rho HS, Kim A, et al. FXR inhibits endoplasmic reticulum stress-induced NLRP3 inflammasome in hepatocytes and ameliorates liver injury. Cell Rep. 2018;24(11):2985–2999. doi:10.1016/j.celrep.2018.07.068
   PubMed Web of Science ®Google Scholar
• Dunagan M, Chaudhry K, Samak G, Rao RK. Acetaldehyde disrupts tight junctions in Caco-2 cell monolayers by a protein phosphatase 2A-dependent mechanism. Am J Physiol Gastrointest Liver Physiol. 2012;303(12):G1356–G1364. doi:10.1152/ajpgi.00526.2011
   PubMed Web of Science ®Google Scholar
• Wang Y, Tong J, Chang B, Wang B, Zhang D, Wang B. Effects of alcohol on intestinal epithelial barrier permeability and expression of tight junction-associated proteins. Mol Med Rep. 2014;9(6):2352–2356. doi:10.3892/mmr.2014.2126
   PubMed Web of Science ®Google Scholar
• Szabo G, Petrasek J, Bala S. Innate immunity and alcoholic liver disease. Dig Dis. 2012;30(Suppl s1):55–60. doi:10.1159/000341126
   PubMedGoogle Scholar
• Petrasek J, Iracheta-Vellve A, Saha B, et al. Metabolic danger signals, uric acid and ATP, mediate inflammatory cross-talk between hepatocytes and immune cells in alcoholic liver disease. J Leukoc Biol. 2015;98(2):249–256. doi:10.1189/jlb.3AB1214-590R
   PubMed Web of Science ®Google Scholar
• Chen H, Zhu J, Liu Y, et al. Lipopolysaccharide induces chronic kidney injury and fibrosis through activation of mTOR signaling in macrophages. Am J Nephrol. 2015;42(4):305–317. doi:10.1159/000441506
   PubMed Web of Science ®Google Scholar
• Tang PC, Zhang YY, Chan MK, et al. The emerging role of innate immunity in chronic kidney diseases. Int J Mol Sci. 2020;21(11):4018. doi:10.3390/ijms21114018
   PubMed Web of Science ®Google Scholar
• Ke B, Shen W, Fang X, Wu Q. The NLPR3 inflammasome and obesity-related kidney disease. J Cell Mol Med. 2018;22(1):16–24. doi:10.1111/jcmm.13333
   PubMed Web of Science ®Google Scholar
• Zhang C, Boini KM, Xia M, et al. Activation of Nod-like receptor protein 3 inflammasomes turns on podocyte injury and glomerular sclerosis in hyperhomocysteinemia. Hypertension. 2012;60(1):154–162. doi:10.1161/HYPERTENSIONAHA.111.189688
   PubMed Web of Science ®Google Scholar
• Shahzad K, Bock F, Dong W, et al. Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy. Kidney Int. 2015;87(1):74–84. doi:10.1038/ki.2014.271
   PubMed Web of Science ®Google Scholar
• Masola V, Carraro A, Granata S, et al. In vitro effects of interleukin (IL)-1 beta inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells. J Transl Med. 2019;17(1):12. doi:10.1186/s12967-019-1770-1
   PubMedGoogle Scholar
• Seo JB, Choi YK, Woo HI, et al. Gemigliptin attenuates renal fibrosis through down-regulation of the NLRP3 inflammasome. Diabetes Metab J. 2019;43(6):830–839. doi:10.4093/dmj.2018.0181
   PubMed Web of Science ®Google Scholar
• Wen Y, Pan MM, Lv LL, et al. Artemisinin attenuates tubulointerstitial inflammation and fibrosis via the NF-κB/NLRP3 pathway in rats with 5/6 subtotal nephrectomy. J Cell Biochem. 2019;120(3):4291–4300. doi:10.1002/jcb.27714
   PubMed Web of Science ®Google Scholar
• Shen X, Dong X, Han Y, et al. Ginsenoside Rg1 ameliorates glomerular fibrosis during kidney aging by inhibiting NOX4 and NLRP3 inflammasome activation in SAMP8 mice. Int Immunopharmacol. 2020;82:106339. doi:10.1016/j.intimp.2020.106339
   PubMed Web of Science ®Google Scholar
• Ling L, Yang M, Ding W, Gu Y. Ghrelin attenuates UUO-induced renal fibrosis via attenuation of Nlrp3 inflammasome and endoplasmic reticulum stress. Am J Transl Res. 2019;11(1):131–141.
   PubMed Web of Science ®Google Scholar
• Wang S, Fan J, Mei X, et al. Interleukin-22 attenuated renal tubular injury in aristolochic acid nephropathy via suppressing activation of NLRP3 inflammasome. Front Immunol. 2019;10:2277. doi:10.3389/fimmu.2019.02277
   PubMed Web of Science ®Google Scholar
• Komada T, Muruve DA. The role of inflammasomes in kidney disease. Nat Rev Nephrol. 2019;15(8):501–520. doi:10.1038/s41581-019-0158-z
   PubMed Web of Science ®Google Scholar
• Komada T, Chung H, Lau A, et al. Macrophage uptake of necrotic cell DNA activates the AIM2 inflammasome to regulate a proinflammatory phenotype in CKD. J Am Soc Nephrol. 2018;29(4):1165–1181. doi:10.1681/ASN.2017080863
   PubMed Web of Science ®Google Scholar
• Meyer KC. Pulmonary fibrosis, part I: epidemiology, pathogenesis, and diagnosis. Expert Rev Respir Med. 2017;11(5):343–359. doi:10.1080/17476348.2017.1312346
   PubMed Web of Science ®Google Scholar
• Hosseinian N, Cho Y, Lockey RF, Kolliputi N. The role of the NLRP3 inflammasome in pulmonary diseases. Ther Adv Respir Dis. 2015;9(4):188–197. doi:10.1177/1753465815586335
   PubMed Web of Science ®Google Scholar
• Sohn SH, Lee JM, Park S, et al. The inflammasome accelerates radiation-induced lung inflammation and fibrosis in mice. Environ Toxicol Pharmacol. 2015;39(2):917–926. doi:10.1016/j.etap.2015.02.019
   PubMed Web of Science ®Google Scholar
• Wang X, Sun B, Liu S, Xia T. Structure activity relationships of engineered nanomaterials in inducing NLRP3 inflammasome activation and chronic lung fibrosis. NanoImpact. 2017;6:99–108. doi:10.1016/j.impact.2016.08.002
   PubMed Web of Science ®Google Scholar
• Hu B, Jin C, Li HB, et al. The DNA-sensing AIM2 inflammasome controls radiation-induced cell death and tissue injury. Science. 2016;354(6313):765–768. doi:10.1126/science.aaf7532
   PubMed Web of Science ®Google Scholar
• Gao J, Peng S, Shan X, et al. Inhibition of AIM2 inflammasome-mediated pyroptosis by Andrographolide contributes to amelioration of radiation-induced lung inflammation and fibrosis. Cell Death Dis. 2019;10(12):957. doi:10.1038/s41419-019-2195-8
   PubMed Web of Science ®Google Scholar
• Varga J, Abraham D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest. 2007;117(3):557–567. doi:10.1172/JCI31139
   PubMed Web of Science ®Google Scholar
• Desbois AC, Cacoub P. Systemic sclerosis: an update in 2016. Autoimmun Rev. 2016;15(5):417–426. doi:10.1016/j.autrev.2016.01.007
   PubMed Web of Science ®Google Scholar
• Ihn H. Autocrine TGF-beta signaling in the pathogenesis of systemic sclerosis. J Dermatol Sci. 2008;49(2):103–113. doi:10.1016/j.jdermsci.2007.05.014
   PubMed Web of Science ®Google Scholar
• Artlett CM, Sassi-Gaha S, Rieger JL, Boesteanu AC, Feghali-Bostwick CA, Katsikis PD. The inflammasome activating caspase 1 mediates fibrosis and myofibroblast differentiation in systemic sclerosis. Arthritis Rheum. 2011;63(11):3563–3574. doi:10.1002/art.30568
   PubMedGoogle Scholar
• Martínez-Godínez MA, Cruz-Domínguez MP, Jara LJ, et al. Expression of NLRP3 inflammasome, cytokines and vascular mediators in the skin of systemic sclerosis patients. Isr Med Assoc J. 2015;17(1):5–10.
   PubMed Web of Science ®Google Scholar
• Weber KT, Brilla CG, Janicki JS. Myocardial fibrosis: functional significance and regulatory factors. Cardiovasc Res. 1993;27(3):341–348. doi:10.1093/cvr/27.3.341
   PubMed Web of Science ®Google Scholar
• Van Tassell BW, Arena R, Biondi-Zoccai G, et al. Effects of interleukin-1 blockade with anakinra on aerobic exercise capacity in patients with heart failure and preserved ejection fraction (from the D-HART pilot study). Am J Cardiol. 2014;113(2):321–327. doi:10.1016/j.amjcard.2013.08.047
   PubMed Web of Science ®Google Scholar
• Sandanger Ø, Gao E, Ranheim T, et al. NLRP3 inflammasome activation during myocardial ischemia reperfusion is cardioprotective. Biochem Biophys Res Commun. 2016;469(4):1012–1020. doi:10.1016/j.bbrc.2015.12.051
   PubMed Web of Science ®Google Scholar
• Kawaguchi M, Takahashi M, Hata T, et al. Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury. Circulation. 2011;123(6):594–604. doi:10.1161/CIRCULATIONAHA.110.982777
   PubMed Web of Science ®Google Scholar
• Zhang X, Pan L, Yang K, et al. H3 relaxin protects against myocardial injury in experimental diabetic cardiomyopathy by inhibiting myocardial apoptosis, fibrosis and inflammation. Cell Physiol Biochem. 2017;43(4):1311–1324. doi:10.1159/000481843
   PubMedGoogle Scholar
• Bracey NA, Gershkovich B, Chun J, et al. Mitochondrial NLRP3 protein induces reactive oxygen species to promote Smad protein signaling and fibrosis independent from the inflammasome. J Biol Chem. 2014;289(28):19571–19584. doi:10.1074/jbc.M114.550624
   PubMed Web of Science ®Google Scholar
• Pan XC, Liu Y, Cen YY, et al. Dual role of triptolide in interrupting the NLRP3 inflammasome pathway to attenuate cardiac fibrosis. Int J Mol Sci. 2019;20(2):360. doi:10.3390/ijms20020360
   PubMed Web of Science ®Google Scholar
• Cáceres FT, Gaspari TA, Samuel CS, Pinar AA. Serelaxin inhibits the profibrotic TGF-β1/IL-1β axis by targeting TLR-4 and the NLRP3 inflammasome in cardiac myofibroblasts. FASEB J. 2019;33(12):14717–14733. doi:10.1096/fj.201901079RR
   PubMed Web of Science ®Google Scholar
• Faria A, Persaud SJ. Cardiac oxidative stress in diabetes: mechanisms and therapeutic potential. Pharmacol Ther. 2017;172:50–62. doi:10.1016/j.pharmthera.2016.11.013
   PubMed Web of Science ®Google Scholar
• Roul D, Recchia FA. Metabolic alterations induce oxidative stress in diabetic and failing hearts: different pathways, same outcome. Antioxid Redox Signal. 2015;22(17):1502–1514. doi:10.1089/ars.2015.6311
   PubMed Web of Science ®Google Scholar
• Wang X, Pan J, Liu H, et al. AIM2 gene silencing attenuates diabetic cardiomyopathy in type 2 diabetic rat model. Life Sci. 2019;221:249–258. doi:10.1016/j.lfs.2019.02.035
   PubMed Web of Science ®Google Scholar
• Liew EL, Araki M, Hironaka Y, et al. Identification of AIM2 as a downstream target of JAK2V617F. Exp Hematol Oncol. 2015;5:2. doi:10.1186/s40164-016-0032-7
   PubMedGoogle Scholar
• Zhou Y, Yan S, Liu N, et al. Genetic polymorphisms and expression of NLRP3 inflammasome-related genes are associated with Philadelphia chromosome-negative myeloproliferative neoplasms. Hum Immunol. 2020;81(10–11):606–613. doi:10.1016/j.humimm.2020.09.001
   PubMed Web of Science ®Google Scholar